ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Liver-focused Ambys launches with $140M, Takeda partnership
fiercebiotech
August 09, 2018Third Rock Ventures is debuting Ambys Medicines, which will develop cell and gene therapies?as well as drugs?for chronic liver diseases. Ambys starts life with $140 million in committed capital, including $100 million from Takeda, part of which came in th
Pharma Sources Insight January 2025
